HEADER OXIDOREDUCTASE/PEPTIDE 19-OCT-10 2XUM TITLE FACTOR INHIBITING HIF (FIH) Q239H MUTANT IN COMPLEX WITH ZN(II), NOG TITLE 2 AND ASP-SUBSTRATE PEPTIDE (20-MER) COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FACTOR INHIBITING HIF-1, FIH-1, HYPOXIA-INDUCIBLE FACTOR COMPND 5 ASPARAGINE HYDROXYLASE; COMPND 6 EC: 1.14.11.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ASP-SUBSTRATE PEPTIDE 2; COMPND 11 CHAIN: S; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET28A(+); SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 12 ORGANISM_TAXID: 32630; SOURCE 13 OTHER_DETAILS: BASED ON BIOLOGICAL SEQUENCE KEYWDS OXIDOREDUCTASE-PEPTIDE COMPLEX, NON-HEME, DIOXYGENASE, OXYGENASE, KEYWDS 2 HYPOXIA, METAL-BINDING, HELIX-LOOP-HELIX-BETA, FACIAL TRIAD KEYWDS 3 SIGNALING, BETA-HYDROXYLATION, TRANSCRIPTION ACTIVATOR/INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR R.CHOWDHURY,M.A.MCDONOUGH,C.J.SCHOFIELD REVDAT 6 20-DEC-23 2XUM 1 REMARK LINK REVDAT 5 30-JAN-19 2XUM 1 REMARK REVDAT 4 07-MAR-18 2XUM 1 SOURCE AUTHOR JRNL REVDAT 3 18-MAR-15 2XUM 1 REMARK REVDAT 2 16-NOV-11 2XUM 1 JRNL REMARK VERSN REVDAT 1 22-DEC-10 2XUM 0 JRNL AUTH M.YANG,W.GE,R.CHOWDHURY,T.D.CLARIDGE,H.B.KRAMER,B.SCHMIERER, JRNL AUTH 2 M.A.MCDONOUGH,L.GONG,B.M.KESSLER,P.J.RATCLIFFE,M.L.COLEMAN, JRNL AUTH 3 C.J.SCHOFIELD JRNL TITL ASPARAGINE AND ASPARTATE HYDROXYLATION OF THE CYTOSKELETAL JRNL TITL 2 ANKYRIN FAMILY IS CATALYZED BY FACTOR-INHIBITING JRNL TITL 3 HYPOXIA-INDUCIBLE FACTOR. JRNL REF J. BIOL. CHEM. V. 286 7648 2011 JRNL REFN ESSN 1083-351X JRNL PMID 21177872 JRNL DOI 10.1074/JBC.M110.193540 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.L.COLEMAN,M.A.MCDONOUGH,K.S.HEWITSON,C.COLES,J.MECINOVIC, REMARK 1 AUTH 2 M.EDELMANN,K.M.COOK,M.E.COCKMAN,D.E.LANCASTER,B.M.KESSLER, REMARK 1 AUTH 3 N.J.OLDHAM,P.J.RATCLIFFE,C.J.SCHOFIELD REMARK 1 TITL ASPARAGINYL HYDROXYLATION OF THE NOTCH ANKYRIN REPEAT DOMAIN REMARK 1 TITL 2 BY FACTOR INHIBITING HYPOXIA-INDUCIBLE FACTOR. REMARK 1 REF J.BIOL.CHEM. V. 282 24027 2007 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 17573339 REMARK 1 DOI 10.1074/JBC.M704102200 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 74.12 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 26863 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1428 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1921 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.16 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE SET COUNT : 98 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2980 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.19000 REMARK 3 B22 (A**2) : -1.19000 REMARK 3 B33 (A**2) : 2.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.215 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.172 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.151 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.189 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3120 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4242 ; 1.034 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 375 ; 5.264 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 168 ;39.338 ;24.821 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 516 ;15.122 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;14.467 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 430 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2467 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1349 ; 0.184 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2092 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 185 ; 0.122 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 1 ; 0.003 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 79 ; 0.197 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.181 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1909 ; 0.260 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2983 ; 0.449 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1404 ; 0.792 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1254 ; 1.200 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2XUM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1290045814. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26863 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 74.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 9.200 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.40 REMARK 200 R MERGE FOR SHELL (I) : 0.88000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.230 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 1.1 REMARK 200 STARTING MODEL: PDB ENTRY 1H2K REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6M AMMONIUM SULPHATE, 6% PEG400, REMARK 280 0.1M HEPES PH7.5, VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.26650 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.17600 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.17600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.13325 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.17600 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.17600 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 108.39975 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.17600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.17600 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.13325 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.17600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.17600 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 108.39975 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.26650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -208.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, S REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 86.35200 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 86.35200 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 72.26650 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -85.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, S REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 239 TO HIS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS S 788 REMARK 465 LEU S 789 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 40 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 202 33.77 -90.73 REMARK 500 ILE A 210 -50.67 -120.09 REMARK 500 ASP A 237 129.14 -39.79 REMARK 500 ARG A 238 -8.50 89.47 REMARK 500 TYR A 276 -5.55 74.29 REMARK 500 ASP S 806 56.22 36.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 RESIDUE OGA IS THE N-OXALYL GLYCINE (NOG). REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 199 NE2 REMARK 620 2 ASP A 201 OD2 109.6 REMARK 620 3 HIS A 279 NE2 93.9 80.3 REMARK 620 4 OGA A 601 O1 162.9 86.2 95.2 REMARK 620 5 OGA A 601 O2' 85.2 163.4 106.9 78.4 REMARK 620 6 HOH A2144 O 74.8 90.9 162.6 99.2 85.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OGA A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 604 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WA4 RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH N,3- DIHYDROXYBENZAMIDE REMARK 900 RELATED ID: 1MZE RELATED DB: PDB REMARK 900 HUMAN FACTOR INHIBITING HIF (FIH1) REMARK 900 RELATED ID: 2W0X RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH PYRIDINE 2,4 DICARBOXYLIC ACID REMARK 900 RELATED ID: 1MZF RELATED DB: PDB REMARK 900 HUMAN FACTOR INHIBITING HIF (FIH1) IN COMPLEX WITH 2-OXOGLUTARATE REMARK 900 RELATED ID: 2CGN RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH SUCCINATE REMARK 900 RELATED ID: 1H2N RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1YCI RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH N-(CARBOXYCARBONYL)-D- REMARK 900 PHENYLALANINE REMARK 900 RELATED ID: 2WA3 RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH 2-(3- HYDROXYPHENYL)-2-OXOACETIC REMARK 900 ACID REMARK 900 RELATED ID: 2CGO RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH FUMARATE REMARK 900 RELATED ID: 1H2K RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1IZ3 RELATED DB: PDB REMARK 900 DIMERIC STRUCTURE OF FIH (FACTOR INHIBITING HIF) REMARK 900 RELATED ID: 1H2L RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1H2M RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE DBREF 2XUM A 1 349 UNP Q9NWT6 HIF1N_HUMAN 1 349 DBREF 2XUM S 788 807 PDB 2XUM 2XUM 788 807 SEQADV 2XUM HIS A 239 UNP Q9NWT6 GLN 239 ENGINEERED MUTATION SEQRES 1 A 349 MET ALA ALA THR ALA ALA GLU ALA VAL ALA SER GLY SER SEQRES 2 A 349 GLY GLU PRO ARG GLU GLU ALA GLY ALA LEU GLY PRO ALA SEQRES 3 A 349 TRP ASP GLU SER GLN LEU ARG SER TYR SER PHE PRO THR SEQRES 4 A 349 ARG PRO ILE PRO ARG LEU SER GLN SER ASP PRO ARG ALA SEQRES 5 A 349 GLU GLU LEU ILE GLU ASN GLU GLU PRO VAL VAL LEU THR SEQRES 6 A 349 ASP THR ASN LEU VAL TYR PRO ALA LEU LYS TRP ASP LEU SEQRES 7 A 349 GLU TYR LEU GLN GLU ASN ILE GLY ASN GLY ASP PHE SER SEQRES 8 A 349 VAL TYR SER ALA SER THR HIS LYS PHE LEU TYR TYR ASP SEQRES 9 A 349 GLU LYS LYS MET ALA ASN PHE GLN ASN PHE LYS PRO ARG SEQRES 10 A 349 SER ASN ARG GLU GLU MET LYS PHE HIS GLU PHE VAL GLU SEQRES 11 A 349 LYS LEU GLN ASP ILE GLN GLN ARG GLY GLY GLU GLU ARG SEQRES 12 A 349 LEU TYR LEU GLN GLN THR LEU ASN ASP THR VAL GLY ARG SEQRES 13 A 349 LYS ILE VAL MET ASP PHE LEU GLY PHE ASN TRP ASN TRP SEQRES 14 A 349 ILE ASN LYS GLN GLN GLY LYS ARG GLY TRP GLY GLN LEU SEQRES 15 A 349 THR SER ASN LEU LEU LEU ILE GLY MET GLU GLY ASN VAL SEQRES 16 A 349 THR PRO ALA HIS TYR ASP GLU GLN GLN ASN PHE PHE ALA SEQRES 17 A 349 GLN ILE LYS GLY TYR LYS ARG CYS ILE LEU PHE PRO PRO SEQRES 18 A 349 ASP GLN PHE GLU CYS LEU TYR PRO TYR PRO VAL HIS HIS SEQRES 19 A 349 PRO CYS ASP ARG HIS SER GLN VAL ASP PHE ASP ASN PRO SEQRES 20 A 349 ASP TYR GLU ARG PHE PRO ASN PHE GLN ASN VAL VAL GLY SEQRES 21 A 349 TYR GLU THR VAL VAL GLY PRO GLY ASP VAL LEU TYR ILE SEQRES 22 A 349 PRO MET TYR TRP TRP HIS HIS ILE GLU SER LEU LEU ASN SEQRES 23 A 349 GLY GLY ILE THR ILE THR VAL ASN PHE TRP TYR LYS GLY SEQRES 24 A 349 ALA PRO THR PRO LYS ARG ILE GLU TYR PRO LEU LYS ALA SEQRES 25 A 349 HIS GLN LYS VAL ALA ILE MET ARG ASN ILE GLU LYS MET SEQRES 26 A 349 LEU GLY GLU ALA LEU GLY ASN PRO GLN GLU VAL GLY PRO SEQRES 27 A 349 LEU LEU ASN THR MET ILE LYS GLY ARG TYR ASN SEQRES 1 S 20 HIS LEU GLU VAL VAL LYS LEU LEU LEU GLU HIS GLY ALA SEQRES 2 S 20 ASP VAL ASP ALA GLN ASP LYS HET ZN A 501 1 HET OGA A 601 10 HET SO4 A 602 5 HET SO4 A 603 5 HET SO4 A 604 5 HETNAM ZN ZINC ION HETNAM OGA N-OXALYLGLYCINE HETNAM SO4 SULFATE ION FORMUL 3 ZN ZN 2+ FORMUL 4 OGA C4 H5 N O5 FORMUL 5 SO4 3(O4 S 2-) FORMUL 8 HOH *154(H2 O) HELIX 1 1 MET A 1 ALA A 10 1 10 HELIX 2 2 GLU A 19 LEU A 23 5 5 HELIX 3 3 ASP A 28 LEU A 32 5 5 HELIX 4 4 ASP A 49 ASN A 58 1 10 HELIX 5 5 VAL A 70 TRP A 76 5 7 HELIX 6 6 ASP A 77 ILE A 85 1 9 HELIX 7 7 LYS A 124 GLY A 139 1 16 HELIX 8 8 GLY A 155 GLY A 164 1 10 HELIX 9 9 ASN A 166 GLY A 178 1 13 HELIX 10 10 PRO A 220 ASP A 222 5 3 HELIX 11 11 GLN A 223 TYR A 228 1 6 HELIX 12 12 PHE A 252 VAL A 258 5 7 HELIX 13 13 LYS A 311 GLY A 331 1 21 HELIX 14 14 ASN A 332 GLN A 334 5 3 HELIX 15 15 GLU A 335 LYS A 345 1 11 HELIX 16 16 GLU S 790 GLU S 797 1 8 SHEET 1 AA 5 THR A 39 PRO A 41 0 SHEET 2 AA 5 GLY A 260 VAL A 265 1 O GLY A 260 N ARG A 40 SHEET 3 AA 5 LYS A 214 PHE A 219 -1 O LYS A 214 N VAL A 265 SHEET 4 AA 5 TRP A 278 SER A 283 -1 O TRP A 278 N PHE A 219 SHEET 5 AA 5 VAL A 195 HIS A 199 -1 O THR A 196 N ILE A 281 SHEET 1 AB 9 ARG A 44 LEU A 45 0 SHEET 2 AB 9 VAL A 62 LEU A 64 1 O VAL A 63 N LEU A 45 SHEET 3 AB 9 VAL A 270 ILE A 273 -1 O VAL A 270 N LEU A 64 SHEET 4 AB 9 GLN A 204 LYS A 211 -1 O ASN A 205 N ILE A 273 SHEET 5 AB 9 THR A 290 TYR A 297 -1 O ILE A 291 N ILE A 210 SHEET 6 AB 9 LEU A 186 GLY A 190 -1 O LEU A 186 N ASN A 294 SHEET 7 AB 9 ARG A 143 THR A 149 -1 O LEU A 146 N ILE A 189 SHEET 8 AB 9 PHE A 90 ALA A 95 -1 O SER A 91 N GLN A 147 SHEET 9 AB 9 SER A 118 MET A 123 -1 O ASN A 119 N SER A 94 SHEET 1 AC 6 ARG A 44 LEU A 45 0 SHEET 2 AC 6 VAL A 62 LEU A 64 1 O VAL A 63 N LEU A 45 SHEET 3 AC 6 VAL A 270 ILE A 273 -1 O VAL A 270 N LEU A 64 SHEET 4 AC 6 GLN A 204 LYS A 211 -1 O ASN A 205 N ILE A 273 SHEET 5 AC 6 THR A 290 TYR A 297 -1 O ILE A 291 N ILE A 210 SHEET 6 AC 6 LEU A 182 SER A 184 -1 N THR A 183 O TRP A 296 LINK NE2 HIS A 199 ZN ZN A 501 1555 1555 2.23 LINK OD2 ASP A 201 ZN ZN A 501 1555 1555 2.02 LINK NE2 HIS A 279 ZN ZN A 501 1555 1555 2.31 LINK ZN ZN A 501 O1 OGA A 601 1555 1555 2.18 LINK ZN ZN A 501 O2' OGA A 601 1555 1555 2.05 LINK ZN ZN A 501 O HOH A2144 1555 1555 2.24 CISPEP 1 TYR A 308 PRO A 309 0 1.02 SITE 1 AC1 5 HIS A 199 ASP A 201 HIS A 279 OGA A 601 SITE 2 AC1 5 HOH A2144 SITE 1 AC2 14 TYR A 145 LEU A 188 THR A 196 HIS A 199 SITE 2 AC2 14 ASP A 201 ASN A 205 PHE A 207 LYS A 214 SITE 3 AC2 14 HIS A 279 ILE A 281 ASN A 294 TRP A 296 SITE 4 AC2 14 ZN A 501 HOH A2144 SITE 1 AC3 4 ARG A 138 GLY A 140 GLU A 141 GLU A 142 SITE 1 AC4 5 ARG A 143 GLU A 192 GLY A 193 LEU A 285 SITE 2 AC4 5 ASN A 286 SITE 1 AC5 4 LYS A 311 ALA A 312 HOH A2146 HOH A2147 CRYST1 86.352 86.352 144.533 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011581 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011581 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006919 0.00000